Doutor Nichires Holdings (3087) Fundamentals 2026 — P/E 16.4x, Revenue Analysis | SniperIQ
Doutor Nichires Holdings (3087) is a JP-listed Consumer Cyclical company in Restaurants with a market capitalization of ¥129.6B, trading at ¥3085.00 on the JPX. This SniperIQ fundamentals page covers Doutor Nichires Holdings's valuation (P/E 16.4x, P/B 1.2x), profitability (net margin 4.9%), revenue (¥159.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Doutor Nichires Holdings's market cap?
Doutor Nichires Holdings (3087) has a market capitalization of approximately ¥129.6B, trading at ¥3085.00 on the JPX. Market cap moves with the live share price.
What is Doutor Nichires Holdings's P/E ratio?
Doutor Nichires Holdings's trailing twelve-month P/E ratio is 16.4x, with a price-to-book (P/B) of 1.2x. Valuation multiples are best compared with Consumer Cyclical sector peers rather than read in isolation.
How profitable is Doutor Nichires Holdings?
Doutor Nichires Holdings runs a net profit margin of 4.9%, a gross margin of 58.8%, and an operating margin of 6.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Doutor Nichires Holdings generate?
Doutor Nichires Holdings reported revenue of ¥159.1B for fiscal year 2025, with net income of ¥7.2B and earnings per share (EPS) of 170.71. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Doutor Nichires Holdings pay a dividend?
Doutor Nichires Holdings offers a trailing dividend yield of about 1.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Doutor Nichires Holdings financially healthy?
Doutor Nichires Holdings carries a debt-to-equity ratio of 0.02x and a current ratio of 2.42x, with a market beta of 0.19. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Doutor Nichires Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Doutor Nichires Holdings (3087) the key facts are: market cap ¥129.6B, P/E 16.4x, revenue ¥159.1B, 52-week range 2377-3125. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Cyclical peers and form your own view.
Track Doutor Nichires Holdings's full fundamentals live
Get Doutor Nichires Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.